These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26434609)

  • 1. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis.
    Prematunge C; MacDougall C; Johnstone J; Adomako K; Lam F; Robertson J; Garber G
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):26-35. PubMed ID: 26434609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
    Stosor V; Peterson LR; Postelnick M; Noskin GA
    Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
    Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
    Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
    Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
    PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
    Patel R; Gallagher JC
    Ann Pharmacother; 2015 Jan; 49(1):69-85. PubMed ID: 25352037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.
    DiazGranados CA; Zimmer SM; Klein M; Jernigan JA
    Clin Infect Dis; 2005 Aug; 41(3):327-33. PubMed ID: 16007529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
    Chuang YC; Wang JT; Lin HY; Chang SC
    BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.
    Eichel VM; Last K; Brühwasser C; von Baum H; Dettenkofer M; Götting T; Grundmann H; Güldenhöven H; Liese J; Martin M; Papan C; Sadaghiani C; Wendt C; Werner G; Mutters NT
    J Hosp Infect; 2023 Nov; 141():119-128. PubMed ID: 37734679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
    Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
    Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations, characteristics, and outcome of infections caused by vancomycin-resistant enterococci at a tertiary care center in Lebanon: A case-case-control study.
    Abi Frem J; Ghanem M; Doumat G; Kanafani ZA
    J Infect Public Health; 2023 May; 16(5):741-745. PubMed ID: 36958169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA; Mickail N; Eisenstein L
    Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
    Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
    Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
    Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
    Johnstone J; Chen C; Rosella L; Adomako K; Policarpio ME; Lam F; Prematunge C; Garber G;
    Am J Infect Control; 2018 Nov; 46(11):1266-1271. PubMed ID: 29903421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.